Evidence map›Paper›PMID 33881475›Full record

ArticleBlood2021

Radiation-induced bystander effects impair transplanted human hematopoietic stem cells via oxidative DNA damage.

Linping Hu, Xiuxiu Yin, Yawen Zhang, Aiming Pang, Xiaowei Xie, Shangda Yang, Caiying Zhu, Yapu Li, Biao Zhang, Yaojin Huang and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Diallyl disulfide reduces oxidative stress to mitigate uranium tailings radiation-induced damage to the hematopoietic system.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 1 country.

Linping HuState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.ORCID 0000-0002-6606-3843
Xiuxiu YinState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Yawen ZhangState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.ORCID 0000-0001-9613-4721
Aiming PangState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Xiaowei XieState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Shangda YangState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.ORCID 0000-0002-9235-4847
Caiying ZhuState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Yapu LiState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Biao ZhangState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Yaojin HuangState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Yunhong TianDepartment of Intensive Care Unit, Key Laboratory for Critical Care Medicine of the Ministry of Health, Emergency Medicine Research Institute, Tianjin First Center Hospital, School of Medicine, Nankai University, Tianjin, China; and.
Mei WangState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Wenbin CaoState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Shulian ChenState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Yawei ZhengState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Shihui MaState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Fang DongState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Sha HaoState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Sizhou FengState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Yongxin RuState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Hui ChengState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.
Erlie JiangState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.ORCID 0000-0002-3937-5518
Tao ChengState Key Laboratory of Experimental Hematology, National Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine and Department of Stem Cell & Regenerative Medicine, Chinese Academy of Medical Sciences-Peking Union Medical College, Tianjin, China.ORCID 0000-0002-5925-2769
Chinese Academy of Medical Sciences & Peking Union Medical College · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Total body irradiation (TBI) is commonly used in host conditioning regimens for human hematopoietic stem cell (HSC) transplantation to treat various hematological disorders. Exposure to TBI not only induces acute myelosuppression and immunosuppression, but also injures the various components of the HSC niche in recipients. Our previous study demonstrated that radiation-induced bystander effects (RIBE) of irradiated recipients decreased the long-term repopulating ability of transplanted mouse HSCs. However, RIBE on transplanted human HSCs have not been studied. Here, we report that RIBE impaired the long-term hematopoietic reconstitution of human HSCs as well as the colony-forming ability of human hematopoietic progenitor cells (HPCs). Our further analyses revealed that the RIBE-affected human hematopoietic cells showed enhanced DNA damage responses, cell-cycle arrest, and p53-dependent apoptosis, mainly because of oxidative stress. Moreover, multiple antioxidants could mitigate these bystander effects, though at different efficacies in vitro and in vivo. Taken together, these findings suggest that RIBE impair human HSCs and HPCs by oxidative DNA damage. This study provides definitive evidence for RIBE on transplanted human HSCs and further justifies the necessity of conducting clinical trials to evaluate different antioxidants to improve the efficacy of HSC transplantation for the patients with hematological or nonhematological disorders.

Indexed as

DNA DamageHematopoietic Stem Cell TransplantationAnimalsBystander EffectFemaleGamma RaysHematopoietic Stem CellsHeterograftsHumansMiceMice, Inbred NODMice, SCIDOxidative StressRadiation Injuries, Experimental

Identifiers

PMID33881475
PMCPMC8233686
OpenAlexW3133504342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.